Christa Osuna

Christa Osuna, PhD MPH, currently serves as the Director of Hematology & Immunology at Prime Medicine, Inc., where responsibilities include supporting IND applications for gene-edited therapies and overseeing flow cytometry assay development. Previous roles include Associate Director at Magenta Therapeutics and Associate Director of Pre-clinical Discovery in Cell Therapy at Flagship Pioneering, where leadership spanned discovery to pre-clinical activities. At Beth Israel Deaconess Medical Center, a substantial focus was on immunological assessments in NHP studies, while earlier work involved postdoctoral research and statistical modeling at Harvard institutions, culminating in a PhD in Immunology from Harvard Medical School and an MPH in Epidemiology from Harvard T.H. Chan School of Public Health.